Ibrutinib repurposing: From B-cell malignancies to solid tumors

Daniel Massó-Vallés; Toni Jauset; Laura Soucek

doi:https://doi.org/10.18632/oncoscience.310

Ibrutinib repurposing: From B-cell malignancies to solid tumors

Daniel Massó-Vallés, Toni Jauset, Laura Soucek

Department of Biochemistry and Molecular Biology

Research output: Contribution to journal › Article › Research › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	147-148
Journal	Oncoscience
Volume	3
Issue number	5-6
DOIs	https://doi.org/10.18632/oncoscience.310
Publication status	Published - 1 May 2016

Keywords

BTK
Drug repurposing
Ibrutinib
Inflammation
Solid tumors

Access to Document

https://doi.org/10.18632/oncoscience.310

https://ddd.uab.cat/record/185945

Cite this

@article{113f77c57a9b4afc807f72d2d40ff20a,

title = "Ibrutinib repurposing: From B-cell malignancies to solid tumors",

keywords = "BTK, Drug repurposing, Ibrutinib, Inflammation, Solid tumors",

author = "Daniel Mass{\'o}-Vall{\'e}s and Toni Jauset and Laura Soucek",

year = "2016",

month = may,

day = "1",

doi = "https://doi.org/10.18632/oncoscience.310",

language = "English",

volume = "3",

pages = "147--148",

journal = "Oncoscience",

issn = "2331-4737",

publisher = "Impact Journals",

number = "5-6",

}

TY - JOUR

T1 - Ibrutinib repurposing: From B-cell malignancies to solid tumors

AU - Massó-Vallés, Daniel

AU - Jauset, Toni

AU - Soucek, Laura

PY - 2016/5/1

Y1 - 2016/5/1

KW - BTK

KW - Drug repurposing

KW - Ibrutinib

KW - Inflammation

KW - Solid tumors

U2 - https://doi.org/10.18632/oncoscience.310

DO - https://doi.org/10.18632/oncoscience.310

M3 - Article

VL - 3

SP - 147

EP - 148

JO - Oncoscience

JF - Oncoscience

SN - 2331-4737

IS - 5-6

ER -